#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucopolysaccharidosis I Thrombocytosis Leiomyosarcoma Postprandial hypoglycaemia Familial amyotrophic lateral sclerosis Polymyositis Oropharyngeal cancer recurrent Scedosporium infection Factor IX deficiency Myeloid leukaemia Noonan syndrome Allogenic stem cell transplantation Anaplastic thyroid cancer Mucous membrane pemphigoid Chronic graft versus host disease in liver More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent – Basic Information Marfan’s syndrome Glomerulonephritis membranous Waldenstrom’s macroglobulinaemia Synovial sarcoma metastatic – Basic Information Piriformis syndrome – Diagnostics Antithrombin III deficiency – Trials in Disease Burkitt’s lymphoma – Life with Disease Breast angiosarcoma – Life with Disease Progressive multifocal leukoencephalopathy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    OLVEREMBATINIB Iodine (123I) Iobenguane Betamethasone Dipropionate Ecoo1A Latanoprost Alxn2220 ULEFNERSEN Amisulpride Foscarnet Sodium Hexahydrate Giroctocogene Fitelparvovec Tinzaparin Sodium Eo2318 Desvenlafaxine Benzoate Evolocumab Xenon (129Xe) Amiloride Hydrochloride Levodopa Infliximab Oxacillin Naproxen More therapies…

    Learn about Your Condition

    Peripheral artery restenosis Antithrombin III deficiency Neuroendocrine carcinoma Primary myelofibrosis Alcohol use disorder Arteriospasm coronary Aneurysm ruptured Growth hormone deficiency Lung transplant Post-traumatic headache Cluster headache Myofascial pain syndrome Atrial flutter Hydrocephalus Primary hyperaldosteronism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Romania

  • Comparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Medullary thyroid cancer
    Investigated Drugs:
    • Cabozantinib
    Croatia Hungary Poland Romania
  • Study Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Cisplatin
    • Pemetrexed
    • Carboplatin
    Croatia Greece Lithuania Poland Romania Spain
  • Study on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome

    Not recruiting

    4 1 1
    Austria Bulgaria Germany Italy The Netherlands Poland +2
  • Long-term safety and effectiveness study of pozelimab and cemdisiran combination treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Cemdisiran
    • Pozelimab
    Greece Hungary Italy Poland Romania Spain
  • Study on the Safety and Effectiveness of Pozelimab and Cemdisiran for Adults with Paroxysmal Nocturnal Hemoglobinuria Not Recently Treated with Complement Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Cemdisiran
    • Pozelimab
    • Eculizumab
    Greece Hungary Italy Poland Romania Spain
  • Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic malignant melanoma
    Investigated Drugs:
    • Nivolumab
    Croatia Czechia Estonia France Germany Hungary +6
Previous Page
1 … 73 74 75 76 77 … 131
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Carboplatin Cisplatin Nivolumab Paclitaxel Pemetrexed Sodium Chloride Docetaxel Dexamethasone Fluorouracil Durvalumab Rituximab Capecitabine Oxaliplatin Prednisolone Paracetamol Gemcitabine Paclitaxel Albumin-Bound Etoposide Pemetrexed Disodium Mycophenolate Mofetil Atezolizumab Dapagliflozin Semaglutide Bevacizumab Tocilizumab Trospium Chloride Xanomeline Tartrate Lenalidomide Ipilimumab Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acquired antithrombin III deficiency Acromegaly Acute cardiac event Acute coronary syndrome Acute haemorrhagic ulcerative colitis Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute myeloid leukaemia Acute myocardial infarction Acute promyelocytic leukaemia Acute respiratory distress syndrome Acute respiratory failure Adenocarcinoma Adenocarcinoma gastric Adenocarcinoma pancreas Adrenogenital syndrome Alcohol use disorder Alopecia areata Alveolar proteinosis Anaemia Anaemia of chronic disease Anaplastic lymphoma kinase gene mutation Angina pectoris Anhedonia Anti-neutrophil cytoplasmic antibody positive vasculitis Antithrombin III deficiency Arteriosclerosis Arteriovenous graft thrombosis Asthma Atrial fibrillation Autism spectrum disorder Autonomic nervous system imbalance Axial spondyloarthritis B-cell lymphoma B-cell small lymphocytic lymphoma Bacterial vaginosis Bipolar disorder Bipolar I disorder Bladder cancer Bladder cancer stage 0 with cancer in situ Bladder cancer stage I with cancer in situ Bladder transitional cell carcinoma stage IV Breast cancer Breast cancer female Breast cancer metastatic Bronchiectasis Cachexia Carcinoid syndrome Cardiac failure Cardiac failure chronic Cardiomyopathy Cardiovascular disorder Cerebrovascular accident prophylaxis Cervix carcinoma Cervix carcinoma recurrent Cholangiocarcinoma Cholangitis sclerosing Chronic cutaneous lupus erythematosus Chronic hepatitis Chronic hepatitis B Chronic hepatitis C Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic myeloid leukaemia Chronic myelomonocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Chronic rhinosinusitis without nasal polyps Clear cell papillary renal cell carcinoma Clear cell renal cell carcinoma Clostridium difficile infection Coagulation factor X level Coeliac disease Cold urticaria Colitis ulcerative Colorectal adenocarcinoma Colorectal cancer Colorectal cancer metastatic Colorectal cancer stage IV Congenital growth hormone deficiency Conjunctivitis allergic Connective tissue disorder Contraception COVID-19 Craniocerebral injury Crohn's disease Cushing's syndrome Cutaneous lupus erythematosus Dementia Alzheimer's type Dementia of the Alzheimer's type with delusions Dermatitis Dermatitis atopic Dermatomyositis Diabetes mellitus Diabetic foot infection Diffuse large B-cell lymphoma Dilated cardiomyopathy Dry age-related macular degeneration Dry eye Duchenne muscular dystrophy Dyslipidaemia EGFR gene mutation Embolism Endocrine ophthalmopathy Endometrial adenocarcinoma Endometrial cancer Endometriosis Epilepsy Epstein-Barr virus associated lymphoma Erosive oesophagitis Essential thrombocythaemia Eyelid ptosis Fabry's disease Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Familial hypertriglyceridaemia Focal segmental glomerulosclerosis Follicle centre lymphoma follicular grade I, II - III Follicular lymphoma Gastric cancer Gastric cancer recurrent Gastroenteropancreatic neuroendocrine tumour disease Gastrointestinal cancer metastatic Gastrooesophageal cancer Gastrooesophageal reflux disease Gingival bleeding Glioma Growth hormone deficiency Haemolytic uraemic syndrome Haemophilia Haemophilia A without inhibitors Haemophilia B without inhibitors Haemorrhage prophylaxis Head and neck cancer Head and neck cancer metastatic Heparin resistance Hepatic cirrhosis Hepatitis B Hepatitis D Hepatobiliary cancer Hepatocellular carcinoma HER2 mutant non-small cell lung cancer HER2 positive breast cancer HER2 positive gastric cancer Hereditary angioedema Hereditary angioedema with C1 esterase inhibitor deficiency Hereditary haemochromatosis Hidradenitis High-grade B-cell lymphoma HIV infection Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Hot flush Human epidermal growth factor receptor negative Human papilloma virus test Huntington's disease Hyperadrenocorticism Hyperchylomicronaemia Hypereosinophilic syndrome Hyperkalaemia Hypertension Hypertriglyceridaemia Hypertrophic cardiomyopathy Hypoparathyroidism Hypophosphatasia Idiopathic pulmonary fibrosis Immune thrombocytopenia Influenza Interstitial lung disease Iron deficiency Ischaemic stroke Juvenile absence epilepsy Juvenile idiopathic arthritis K-ras gene mutation Lennox-Gastaut syndrome Lipoprotein metabolism disorder Lung adenocarcinoma Lung neoplasm malignant Lupus nephritis Major depression Malignant lymphoid neoplasm Malignant melanoma Malignant melanoma stage II Malignant melanoma stage III Malignant melanoma stage IV Malignant peritoneal neoplasm Mania Mantle cell lymphoma Marginal zone lymphoma Medullary thyroid cancer Meningococcal infection Metabolic dysfunction-associated liver disease Metabolic dysfunction-associated steatohepatitis Metastatic gastric cancer Metastatic malignant melanoma Metastatic renal cell carcinoma Microsatellite instability cancer Migraine Migraine with aura Migraine without aura Multiple sclerosis Myasthenia gravis Myelodysplastic syndrome Myelofibrosis Myocardial infarction Myocardial ischaemia Neoplasm Neoplasm malignant Nephrogenic anaemia Neurodermatitis Neurogenic bladder Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer recurrent Non-small cell lung cancer stage I Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV Obesity Oesophageal adenocarcinoma Oesophageal adenocarcinoma stage II Oesophageal adenocarcinoma stage III Oesophageal cancer metastatic Oesophageal carcinoma Oesophageal squamous cell carcinoma Oesophageal squamous cell carcinoma stage II Oesophageal squamous cell carcinoma stage III Osteoarthritis Osteochondrodysplasia Ovarian cancer Ovarian cancer metastatic Ovarian cancer recurrent Ovarian cancer stage III Ovarian cancer stage IV Ovarian epithelial cancer Ovarian epithelial cancer recurrent Overweight Pancreatic carcinoma metastatic Papilloma viral infection Paroxysmal nocturnal haemoglobinuria Partial seizures Pemphigoid Petit mal epilepsy Philadelphia positive acute lymphocytic leukaemia Pituitary-dependent Cushing's syndrome Plasma cell myeloma Plasma cell myeloma refractory Platelet aggregation Platelet aggregation inhibition Platelet aggregation test Pneumonia Portal hypertension Postoperative wound infection Prader-Willi syndrome Primary biliary cholangitis Primary myelofibrosis Primary progressive multiple sclerosis Progressive multiple sclerosis Progressive relapsing multiple sclerosis Prophylaxis of nausea and vomiting Prostate cancer Prostate cancer metastatic Psoriasis Psoriatic arthropathy Psychotic disorder Pulmonary arterial hypertension Pulmonary hypertension Pulmonary tuberculosis Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal cancer metastatic Renal cancer stage IV Renal cell carcinoma Renal disorder Respiratory syncytial virus infection Retinopathy of prematurity Rheumatoid arthritis Schizophrenia Secondary immunodeficiency Secondary progressive multiple sclerosis Short stature Sjogren's syndrome Skin bacterial infection Skin cancer Skin neoplasm excision Skin squamous cell carcinoma metastatic Skin squamous cell carcinoma recurrent Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Small cell lung cancer metastatic Small cell lung cancer recurrent Squamous cell carcinoma Squamous cell carcinoma of head and neck Squamous cell carcinoma of lung Squamous cell carcinoma of skin Still's disease Stress Subacute cutaneous lupus erythematosus Systemic candida Systemic lupus erythematosus Systemic scleroderma Thrombocytopenia Thrombocytosis Thrombosis prophylaxis Thyroid cancer Tourette's disorder Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Transitional cell carcinoma metastatic Triple negative breast cancer Type 1 diabetes mellitus Type 2 diabetes mellitus Urinary incontinence Urinary tract infection Urticaria cholinergic Urticaria chronic Varicella Vomiting Vulvovaginal candidiasis Warm autoimmune haemolytic anaemia Weight control

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!